Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
14.76
+0.14 (0.96%)
At close: Aug 29, 2025, 4:00 PM
14.76
0.00 (0.00%)
After-hours: Aug 29, 2025, 4:20 PM EDT

Avadel Pharmaceuticals Stock Forecast

Stock Price Forecast

The 7 analysts that cover Avadel Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $19.86, which forecasts a 34.55% increase in the stock price over the next year. The lowest target is $12 and the highest is $30.

Price Target: $19.86 (+34.55%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$12$19.86$20$30
Change-18.70%+34.55%+35.50%+103.25%

Analyst Ratings

The average analyst rating for Avadel Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy555555
Buy222222
Hold000000
Sell000000
Strong Sell000000
Total777777

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Strong Buy
Maintains
$13$20
Strong BuyMaintains$13$20+35.50%Aug 21, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$22$24
Strong BuyMaintains$22$24+62.60%Aug 8, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$22
Strong BuyInitiates$22+49.05%Jul 18, 2025
Needham
Needham
Strong Buy
Reiterates
$19
Strong BuyReiterates$19+28.73%May 8, 2025
Needham
Needham
Strong Buy
Reiterates
$19
Strong BuyReiterates$19+28.73%Apr 9, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
276.97M
from 169.12M
Increased by 63.77%
Revenue Next Year
359.80M
from 276.97M
Increased by 29.91%
EPS This Year
0.24
from -0.51
EPS Next Year
0.81
from 0.24
Increased by 234.34%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
22.33M--27.96M169.12M276.97M359.80M
Revenue Growth
-62.28%---504.79%63.77%29.91%
EPS
0.13-1.32-2.29-2.00-0.510.240.81
EPS Growth
------234.34%
Forward PE
-----61.0218.25
No. Analysts
-----1010
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High288.6M397.2M
Avg277.0M359.8M
Low255.2M327.0M

Revenue Growth

Revenue Growth20252026202720282029
High
70.7%
43.4%
Avg
63.8%
29.9%
Low
50.9%
18.1%

EPS Forecast

EPS202520262027
High0.361.30
Avg0.240.81
Low0.170.48

EPS Growth

EPS Growth202520262027
High-
438.3%
Avg-
234.3%
Low-
98.5%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.